Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 14.49
1.97 %
$ 918 M
Market Cap
-15.92
P/E
Price Target
Average
65.63%
Revenue Forecast
Estimate
50.13%
EBIT
Estimate
--105.62%
Net Income
Estimate
59.41%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evolus, Inc.
Wall Street analysts predict an average 1-year price target for EOLS of $24 , with forecasts ranging from
a
low of
$20 to a high of $27 .
EOLS Lowest Price Target
Wall Street Target
20 USD
38.03%
EOLS Average Price Target
Wall Street Target
24 USD
65.63%
EOLS Highest Price Target
Wall Street Target
27 USD
86.34%
REVENUE FORECAST
Revenue Forecast Chart EOLS
EBIT FORECAST
EBIT Forecast Chart EOLS
NET INCOME FORECAST
Net Income Chart EOLS